American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research jointly filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of La-Z-Boy Incorporated common stock as of September 30, 2026.
Key Highlights
- Three reporting persons: American Century Investment Management, Inc. (investment adviser), American Century Companies, Inc. (holding company), and Stowers Institute for Medical Research (control entity) are named as filers.
- 2,014,967 shares: Each reporting person reported aggregate beneficial ownership of 2,014,967 shares of La-Z-Boy Incorporated common stock.
- 5.0% of class: The aggregate position represents 5.0% of La-Z-Boy's outstanding common stock, according to the filing.
- Sole voting and dispositive power: All 2,014,967 shares are held with sole voting power and sole dispositive power; shared voting and shared dispositive power are each reported as 0.
- Event date September 30, 2026: The date of the event requiring this filing is stated as 09/30/2026.
- Ordinary course certification: The filing certifies the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
American Century and Stowers Institute Report Joint 5.0% Position in La-Z-Boy Common Stock
According to the Schedule 13G filed on November 16, 2026, three affiliated entities jointly reported a 5.0% beneficial ownership position in La-Z-Boy Incorporated (NYSE:LZB) common stock. The reporting persons are American Century Investment Management, Inc. ("ACIM"), identified as an investment adviser incorporated in Delaware; American Century Companies, Inc. ("ACC"), a Delaware holding company; and Stowers Institute for Medical Research, a Delaware entity that the filing describes as the control entity of ACC. ACIM is described in the filing as "a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940."
Each of the three reporting persons listed identical figures: 2,014,967 shares beneficially owned, with sole voting power of 2,014,967, sole dispositive power of 2,014,967, and shared voting and shared dispositive power each reported as 0. The filing notes that various persons, including investment companies and separate institutional investor accounts that ACIM advises, "have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." The filing further states that "not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM."
The filing was signed on November 16, 2026, by John Pak, Senior Vice President of both ACIM and ACC, and by Joselyn Verschelden, Authorized Signer for Stowers Institute for Medical Research. La-Z-Boy Incorporated is headquartered at One LA-Z-BOY Drive, Monroe, Michigan 48162, according to the filing.
What Was Disclosed
Three affiliated entities filed a joint Schedule 13G disclosing 2,014,967 shares, or 5.0%, of La-Z-Boy Incorporated common stock as of September 30, 2026, with all voting and dispositive power held on a sole basis and none shared.




Please wait processing your request...